title: Exploitation of the interaction of measles virus fusogenic envelope proteins with the surface receptor CD46 on human cells for microcell-mediated chromosome transfer.
abstract: BACKGROUND
  Microcell-mediated chromosome transfer (MMCT) is a technique by which a chromosome(s) is moved from donor to recipient cells by microcell fusion. Polyethylene glycol (PEG) has conventionally been used as a fusogen, and has been very successful in various genetic studies. However, PEG is not applicable for all types of recipient cells, because of its cell type-dependent toxicity. The cytotoxicity of PEG limits the yield of microcell hybrids to low level (10-6 to 10-5 per recipient cells). To harness the full potential of MMCT, a less toxic and more efficient fusion protocol that can be easily manipulated needs to be developed.
  
  
  RESULTS
  Microcell donor CHO cells carrying a human artificial chromosome (HAC) were transfected with genes encoding hemagglutinin (H) and fusion (F) proteins of an attenuated Measles Virus (MV) Edmonston strain. Mixed culture of the CHO transfectants and MV infection-competent human fibrosarcoma cells (HT1080) formed multinucleated syncytia, suggesting the functional expression of the MV-H/F in the CHO cells. Microcells were prepared and applied to HT1080 cells, human immortalized mesenchymal stem cells (hiMSC), and primary fibroblasts. Drug-resistant cells appeared after selection in culture with Blasticidin targeted against the tagged selection marker gene on the HAC. The fusion efficiency was determined by counting the total number of stable clones obtained in each experiment. Retention of the HAC in the microcell hybrids was confirmed by FISH analyses. The three recipient cell lines displayed distinct fusion efficiencies that depended on the cell-surface expression level of CD46, which acts as a receptor for MV. In HT1080 and hiMSC, the maximum efficiency observed was 50 and 100 times greater than that using conventional PEG fusion, respectively. However, the low efficiency of PEG-induced fusion with HFL1 was not improved by the MV fusogen.
  
  
  CONCLUSIONS
  Ectopic expression of MV envelope proteins provides an efficient recipient cell-oriented MMCT protocol, facilitating extensive applications for studies of gene function and genetic corrections.
authors.affiliation: Chromosome Engineering Research Center, Tottori University, Yonago 683-8503, Japan.
authors.forename: Motonobu
authors.initials: M
authors.lastname: Katoh
authors.forename: Yasuhiro
authors.initials: Y
authors.lastname: Kazuki
authors.forename: Kanako
authors.initials: K
authors.lastname: Kazuki
authors.forename: Naoyo
authors.initials: N
authors.lastname: Kajitani
authors.forename: Masato
authors.initials: M
authors.lastname: Takiguchi
authors.forename: Yuji
authors.initials: Y
authors.lastname: Nakayama
authors.forename: Takafumi
authors.initials: T
authors.lastname: Nakamura
authors.forename: Mitsuo
authors.initials: M
authors.lastname: Oshimura
mesh_terms: D000818:Animals; D016466:CHO Cells; D002459:Cell Fusion / Q000379:methods*; D045744:Cell Line, Tumor; D022222:Chromosomes, Artificial, Human; D006224:Cricetinae; D003412:Cricetulus; D005822:Genetic Vectors; D006801:Humans; D008459:Measles virus; D051916:Membrane Cofactor Protein / Q000737:chemistry*; D014759:Viral Envelope Proteins / Q000737:chemistry*
chemical_list: D051916:Membrane Cofactor Protein; D014759:Viral Envelope Proteins
references.citation: Nat Genet. 2009 Feb;41(2):234-9
references.pmid: 19136951
references.citation: Hum Mol Genet. 1994 Aug;3(8):1245-57
references.pmid: 7987298
references.citation: Hybridoma (Larchmt). 2007 Oct;26(5):296-301
references.pmid: 17979545
references.citation: Mamm Genome. 2003 Sep;14(9):583-92
references.pmid: 14629108
references.citation: Chromosoma. 2005 Sep;114(4):263-74
references.pmid: 16133353
references.citation: Cancer Res. 2008 Oct 15;68(20):8465-72
references.pmid: 18922920
references.citation: J Virol. 2000 Nov;74(21):9928-36
references.pmid: 11024120
references.citation: Methods Mol Biol. 2006;325:59-66
references.pmid: 16761719
references.citation: Hum Mol Genet. 2009 May 15;18(10):1869-78
references.pmid: 19270026
references.citation: Blood. 2001 Jun 15;97(12):3746-54
references.pmid: 11389012
references.citation: Biochem Biophys Res Commun. 2002 Jul 12;295(2):354-61
references.pmid: 12150956
references.citation: Curr Top Microbiol Immunol. 2009;329:59-76
references.pmid: 19198562
references.citation: Radiat Res. 2007 Jun;167(6):675-81
references.pmid: 17523850
references.citation: J Cell Biol. 1985 Oct;101(4):1578-90
references.pmid: 4044645
references.citation: Cancer Res. 2008 Jul 15;68(14):5546-51
references.pmid: 18632606
references.citation: Cytotechnology. 1994;15(1-3):31-50
references.pmid: 7765945
references.citation: Nat Biotechnol. 2004 Mar;22(3):331-6
references.pmid: 14990955
references.citation: Oncogene. 2005 Nov 21;24(52):7775-91
references.pmid: 16299537
references.citation: Theriogenology. 2003 Jan 1;59(1):107-13
references.pmid: 12499022
references.citation: Trends Biotechnol. 2009 May;27(5):259-65
references.pmid: 19327858
references.citation: Mol Ther. 2009 Feb;17(2):309-17
references.pmid: 19034264
references.citation: Cancer Res. 2004 Jul 15;64(14):4919-26
references.pmid: 15256464
references.citation: Cancer Res. 2009 Feb 15;69(4):1459-68
references.pmid: 19208845
references.citation: Exp Hematol. 2007 Mar;35(3):343-9
references.pmid: 17309814
references.citation: Eur J Cancer. 1997 Apr;33(5):710-5
references.pmid: 9282109
references.citation: Hum Mol Genet. 2001 May 15;10(11):1163-75
references.pmid: 11371509
references.citation: Mol Cell. 2006 Sep 1;23(5):733-42
references.pmid: 16949368
references.citation: J Cell Biol. 1983 Jan;96(1):151-9
references.pmid: 6826645
references.citation: Nat Genet. 1997 Jun;16(2):133-43
references.pmid: 9171824
references.citation: J Cell Biol. 1985 Oct;101(4):1591-8
references.pmid: 4044646
references.citation: Curr Gene Ther. 2008 Jun;8(3):162-75
references.pmid: 18537591
references.citation: Reprod Biomed Online. 2008 Jan;16(1):57-69
references.pmid: 18252049
references.citation: Biochem Biophys Res Commun. 2004 Aug 20;321(2):280-90
references.pmid: 15358173
references.citation: Nat Biotechnol. 2005 Feb;23(2):209-14
references.pmid: 15685166